ConductScience.org, home

Paper34838121

Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma.

Lu JC and 14 others. J Hematol Oncol, 2021. Cited by 145 papers, by iCite.

Cite this record

ConductScience Library. Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma. Papers, record 34838121. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34838121

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma.
PubMed
Journal
J Hematol Oncol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
145
iCite
Relative citation ratio, by iCite
7.71
iCite
Revised in PubMed
2022-02-07
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lu JCJia-Cheng
2Zhang PFPeng-Fei
3Huang XYXiao-Yong
4Guo XJXiao-Jun
5Gao CChao
6Zeng HYHai-Ying
7Zheng YMYi-Min
8Wang SWSi-Wei
9Cai JBJia-Bin
10Sun QMQi-Man
11Shi YHYing-Hong
12Zhou JJian
13Ke AWAi-Wu
14Shi GMGuo-Ming
15Fan JJia

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenosineMajor topic
Carcinoma, HepatocellularMajor topic
Drug Resistance, NeoplasmMajor topic
Immune Checkpoint InhibitorsMajor topic
Liver NeoplasmsMajor topic
Cell Line, Tumor
Humans
Signal Transduction

Source PubMed

Download CSV of topics

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125403716Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.Cancer Immunol Res2015https://conductscience.org/library/papers/25403716PubMed
231404607Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment.Semin Cancer Biol2019https://conductscience.org/library/papers/31404607PubMed
317077301HIF-dependent induction of adenosine A2B receptor in hypoxia.FASEB J2006https://conductscience.org/library/papers/17077301PubMed
432641297Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid Leukemia.Cancer Discov2020https://conductscience.org/library/papers/32641297PubMed
531790344Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial.J Clin Oncol2020https://conductscience.org/library/papers/31790344PubMed
630971294CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis.J Hematol Oncol2019https://conductscience.org/library/papers/30971294PubMed
725891174Pembrolizumab for the treatment of non-small-cell lung cancer.N Engl J Med2015https://conductscience.org/library/papers/25891174PubMed
830735636The Landscape of Circular RNA in Cancer.Cell2019https://conductscience.org/library/papers/30735636PubMed
929059149Targeting immunosuppressive adenosine in cancer.Nat Rev Cancer2017https://conductscience.org/library/papers/29059149PubMed
1030755690The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy.Nat Rev Cancer2019https://conductscience.org/library/papers/30755690PubMed
1123724846Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.N Engl J Med2013https://conductscience.org/library/papers/23724846PubMed
1233985545CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity.Mol Cancer2021https://conductscience.org/library/papers/33985545PubMed
1327899277Protective role of hypoxia-inducible factor-1α-dependent CD39 and CD73 in fulminant acute liver failure.Toxicol Appl Pharmacol2017https://conductscience.org/library/papers/27899277PubMed
1425127858Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors.J Immunol2014https://conductscience.org/library/papers/25127858PubMed
1532430013Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.Mol Cancer2020https://conductscience.org/library/papers/32430013PubMed
1633538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
1732503591Non-coding RNAs shuttled via exosomes reshape the hypoxic tumor microenvironment.J Hematol Oncol2020https://conductscience.org/library/papers/32503591PubMed
1830735634Widespread and Functional RNA Circularization in Localized Prostate Cancer.Cell2019https://conductscience.org/library/papers/30735634PubMed
1919349973Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.Nat Biotechnol2009https://conductscience.org/library/papers/19349973PubMed
2032640203Cancer Cells Don't Live Alone: Metabolic Communication within Tumor Microenvironments.Dev Cell2020https://conductscience.org/library/papers/32640203PubMed

See all 38 referencesDownload CSV of references

Cited by111

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 145 citations.

PMIDTitleJournalYearIn PapersSource
42947178Targeting circular RNAs to overcome therapeutic resistance in liver cancer: from mechanisms to clinical prospects.Mol Cancer2026https://conductscience.org/library/papers/42947178PubMed
42909923Portal Vein Tumor Thrombus in Hepatocellular Carcinoma: An Immune Sanctuary Driving Immune Exclusion and Therapeutic Resistance.Liver Cancer2026https://conductscience.org/library/papers/42909923PubMed
42835409Functional heterogeneity of exosomes in hepatocellular carcinoma (Review).Exp Ther Med2026https://conductscience.org/library/papers/42835409PubMed
42819771Immune escape in portal vein tumor thrombus: an intravascular tumor-immune niche framework for hepatocellular carcinoma.Front Immunol2026https://conductscience.org/library/papers/42819771PubMed
42757479Exosomal circular RNAs in the tumor immune microenvironment: From regulatory mechanisms to therapeutic opportunities and translational hurdles (Review).Int J Mol Med2026https://conductscience.org/library/papers/42757479PubMed
42707968Adenosine signaling in tumor immune escape: metabolic checkpoints, myeloid suppression, and combination immunotherapy.Front Oncol2026https://conductscience.org/library/papers/42707968PubMed
42395637Emerging role of proteomics in advancing diagnosis, prognosis, and treatment of liver cancer.Liver Res2026https://conductscience.org/library/papers/42395637PubMed
42321851Extracellular vesicles in solid tumors: from tumor ecology to engineered therapeutics.Mol Cancer2026https://conductscience.org/library/papers/42321851PubMed
42286649Circular RNAs in tumor biology and immunology: molecular mechanisms and therapeutic implications.Mol Cancer2026https://conductscience.org/library/papers/42286649PubMed
42196608Regulatory T Cells in Hepatocellular Carcinoma: Spatial Niches, Biomarkers, and Clinical Implications.Int J Mol Sci2026https://conductscience.org/library/papers/42196608PubMed
42112389Roles of exosomal non-coding RNAs in osteoarthritis.Front Immunol2026https://conductscience.org/library/papers/42112389PubMed
42074315Novel Insights into the Role of circRNAs in Cancer Immunotherapy Resistance and Clinical Implications.Int J Mol Sci2026https://conductscience.org/library/papers/42074315PubMed
42051530Overcoming immune resistance in hepatocellular carcinoma: insights into mechanisms, predictive factors, and interventional strategies.Front Immunol2026https://conductscience.org/library/papers/42051530PubMed
42036237[Research progress on poor response, resistance mechanisms, and influencing factors of immunotherapy for hepatocellular carcinoma].Zhonghua Gan Zang Bing Za Zhi2026https://conductscience.org/library/papers/42036237PubMed
41832910The controversial role of metabolic reprogramming in anti-tumor therapy resistance.Discov Oncol2026https://conductscience.org/library/papers/41832910PubMed
41763068A2AR as a key target for immune microenvironment remodeling in prostate cancer.Transl Oncol2026https://conductscience.org/library/papers/41763068PubMed
41673369HBV reprograms the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic implications.Clin Exp Med2026https://conductscience.org/library/papers/41673369PubMed
41662387MicroRNA-488-3p-loaded engineered exosomes inhibit proliferation, migration and invasion of hepatocellular carcinoma by targeting SEC61G.PLoS One2026https://conductscience.org/library/papers/41662387PubMed
41514551Mechanisms of Immune Checkpoint Inhibitor Resistance in Hepatocellular Carcinoma and Strategies for Reversal.Cancers (Basel)2025https://conductscience.org/library/papers/41514551PubMed
41416448Exosomal circRNAs in hepatocellular carcinoma: Implications for the development and therapeutic resistance of hepatocellular carcinoma (Review).Int J Oncol2026https://conductscience.org/library/papers/41416448PubMed

See all 111 cited byDownload CSV of cited by

Genes30

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD1639332PubTator's text mininghttps://conductscience.org/library/genes/9332NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD63967PubTator's text mininghttps://conductscience.org/library/genes/967NCBI Gene
CD68968PubTator's text mininghttps://conductscience.org/library/genes/968NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
ENTPD1953PubTator's text mininghttps://conductscience.org/library/genes/953NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
GPR151134391PubTator's text mininghttps://conductscience.org/library/genes/134391NCBI Gene
HAVCR284868PubTator's text mininghttps://conductscience.org/library/genes/84868NCBI Gene
HIF1A3091PubTator's text mininghttps://conductscience.org/library/genes/3091NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
ITGAM3684PubTator's text mininghttps://conductscience.org/library/genes/3684NCBI Gene
ITGAX3687PubTator's text mininghttps://conductscience.org/library/genes/3687NCBI Gene
KRT83856PubTator's text mininghttps://conductscience.org/library/genes/3856NCBI Gene
MIR1298100302153PubTator's text mininghttps://conductscience.org/library/genes/100302153NCBI Gene
MRC14360PubTator's text mininghttps://conductscience.org/library/genes/4360NCBI Gene
NCAM14684PubTator's text mininghttps://conductscience.org/library/genes/4684NCBI Gene
NT5E4907PubTator's text mininghttps://conductscience.org/library/genes/4907NCBI Gene

See all 30 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34838121

GET https://conductscience.org/api/papers/v1/34838121/references?page=2